What are Equity Story’s views on Capitol Health Ltd (CAJ)?


Has been recovering very well and recent announcements have added tailwinds to this contrarian play. FY17 results in August will be key together with outlook but already the bottom line is looking better after a period of underperformance. We feel this could go much higher as CAJ continues to focus on its core operations. The turnaround plan and restructure of the business will take some time; hence we believe we are at a relatively early period of business and share price recovery.

Leave a Reply

Your email address will not be published. Required fields are marked *